Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice
- PMID: 9294128
- PMCID: PMC508341
- DOI: 10.1172/JCI119683
Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice
Abstract
Heat-stable enterotoxins (STa), which cause an acute secretory diarrhea, have been suggested to mediate their actions through the guanylyl cyclase-C (GC-C) receptor. The GC-C gene was disrupted by insertion of neo into exon 1 and subsequent homologous recombination. GC-C null mice contained no detectable GC-C protein. Intestine mucosal guanylyl cyclase activity was approximately 16-fold higher in wild-type mice than in the GC-C null mice, and STa-stimulable guanylyl cyclase activity was absent in the null animals. Thus, GC-C is the major cyclase activity present in the intestine, and also completely accounts for the STa-induced elevations of cGMP. Gavage with STa resulted in marked fluid accumulation within the intestine of wild-type and heterozygous suckling mice, but GC-C null animals were resistant. In addition, infection with enterotoxigenic bacteria that produce STa led to diarrhea and death in wild-type and heterozygous mice, while the null mice were protected. Cholera toxin, in contrast, continued to cause diarrhea in GC-C null mice, demonstrating that the cAMP signaling pathway remained intact. Markedly different diets (high carbohydrate, fat, or protein) or the inclusion of high salt (K+, Na+) in the drinking water or diet also did not severely affect the null animals. Given that GC-C is a major intestinal receptor in all mammals, the pressure to retain a functional GC-C in the face of diarrhea-inflicted mortality remains unexplained. Therefore, GC-C likely provides a protective effect against stressors not yet tested, possibly pathogens other than noninvasive enterotoxigenic bacteria.
Similar articles
-
Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion.Biochem Biophys Res Commun. 1997 Oct 20;239(2):463-6. doi: 10.1006/bbrc.1997.7487. Biochem Biophys Res Commun. 1997. PMID: 9344852
-
E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.Trans Am Clin Climatol Assoc. 2003;114:67-85; discussion 85-6. Trans Am Clin Climatol Assoc. 2003. PMID: 12813912 Free PMC article. Review.
-
A role for guanylate cyclase C in acid-stimulated duodenal mucosal bicarbonate secretion.Am J Physiol Gastrointest Liver Physiol. 2004 Jan;286(1):G95-G101. doi: 10.1152/ajpgi.00087.2003. Epub 2003 Jul 24. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 12881226
-
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.Kidney Int. 2004 Jan;65(1):40-53. doi: 10.1111/j.1523-1755.2004.00375.x. Kidney Int. 2004. PMID: 14675035
-
Enterotoxin/guanylin receptor type guanylyl cyclases in non-mammalian vertebrates.Zoolog Sci. 2005 May;22(5):501-9. doi: 10.2108/zsj.22.501. Zoolog Sci. 2005. PMID: 15930822 Review.
Cited by
-
The evolutionary divergence of receptor guanylyl cyclase C has implications for preclinical models for receptor-directed therapeutics.J Biol Chem. 2024 Jan;300(1):105505. doi: 10.1016/j.jbc.2023.105505. Epub 2023 Nov 27. J Biol Chem. 2024. PMID: 38029963 Free PMC article.
-
Enteroendocrine cell regulation of the gut-brain axis.Front Neurosci. 2023 Nov 7;17:1272955. doi: 10.3389/fnins.2023.1272955. eCollection 2023. Front Neurosci. 2023. PMID: 38027512 Free PMC article. Review.
-
Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics.Front Mol Neurosci. 2023 Jan 4;15:1076799. doi: 10.3389/fnmol.2022.1076799. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36683859 Free PMC article. Review.
-
Intestinal neuropod cell GUCY2C regulates visceral pain.J Clin Invest. 2023 Feb 15;133(4):e165578. doi: 10.1172/JCI165578. J Clin Invest. 2023. PMID: 36548082 Free PMC article.
-
Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.Front Endocrinol (Lausanne). 2022 Jun 29;13:911459. doi: 10.3389/fendo.2022.911459. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846281 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
